PAI-1 Expression in Non-scarring Hair Loss
Stopped early
Conditions studied: Androgenetic Alopecia, Telogen Effluvium, Alopecia Areata
In brief
This study will investigate whether subjects who suffer from hair loss have increased levels of PAI-1 compared to age-matched control subjects. The level of PAI-1 expression will be determined in subjects without hair loss and in subjects with non-scarring hair loss, including androgenetic alopecia, telogen effluvium and alopecia areata.
Key facts
- Study ID
- NCT02548689
- Run by
- Northwestern University
- People needed
- 10
- Starts
- 2015-07-01
- Expected to finish
- 2021-06-01
- Last updated by the study team
- 2022-06-09
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age-matched control subjects who do not have a history of hair loss
- A clinical and pathologic diagnosis of androgenetic alopecia, telogen effluvium, alopecia areata or normal scalp skin
- All subjects must have given signed, informed consent prior to registration in study
You may not qualify if…
- History of previous hair transplantation
- Current and past use of medications topically on the scalp
- Clinical or pathologic diagnosis of a scarring alopecia
- History of inflammatory conditions of the scalp such as psoriasis
Where it is running
- Northwestern University Department of Dermatology — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.